AR103119A1 - Uso de elsiglutida para tratar mucositis gastrointestinal, incluyendo diarrea inducida por quimioterapia - Google Patents
Uso de elsiglutida para tratar mucositis gastrointestinal, incluyendo diarrea inducida por quimioterapiaInfo
- Publication number
- AR103119A1 AR103119A1 ARP150102872A ARP150102872A AR103119A1 AR 103119 A1 AR103119 A1 AR 103119A1 AR P150102872 A ARP150102872 A AR P150102872A AR P150102872 A ARP150102872 A AR P150102872A AR 103119 A1 AR103119 A1 AR 103119A1
- Authority
- AR
- Argentina
- Prior art keywords
- chemotherapy
- elsiglutida
- gastrointestinal mucositis
- treat gastrointestinal
- including diarrhea
- Prior art date
Links
- 206010012735 Diarrhoea Diseases 0.000 title abstract 2
- 206010064147 Gastrointestinal inflammation Diseases 0.000 title abstract 2
- 238000002512 chemotherapy Methods 0.000 title abstract 2
- 208000018925 gastrointestinal mucositis Diseases 0.000 title abstract 2
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 229950001278 elsiglutide Drugs 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462048520P | 2014-09-10 | 2014-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR103119A1 true AR103119A1 (es) | 2017-04-19 |
Family
ID=54548212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150102872A AR103119A1 (es) | 2014-09-10 | 2015-09-09 | Uso de elsiglutida para tratar mucositis gastrointestinal, incluyendo diarrea inducida por quimioterapia |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20160067311A1 (enExample) |
| EP (1) | EP3191115A1 (enExample) |
| JP (1) | JP2017532308A (enExample) |
| KR (1) | KR20170052661A (enExample) |
| CN (1) | CN107073081A (enExample) |
| AR (1) | AR103119A1 (enExample) |
| AU (1) | AU2015313919A1 (enExample) |
| BR (1) | BR112017004577A2 (enExample) |
| CA (1) | CA2959110A1 (enExample) |
| CL (1) | CL2017000563A1 (enExample) |
| EA (1) | EA201790552A1 (enExample) |
| IL (1) | IL250928A0 (enExample) |
| MA (1) | MA40623A (enExample) |
| MX (1) | MX2017003166A (enExample) |
| PH (1) | PH12017500426A1 (enExample) |
| SG (1) | SG11201701690WA (enExample) |
| TW (1) | TW201613634A (enExample) |
| WO (1) | WO2016038455A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170087216A1 (en) * | 2015-09-17 | 2017-03-30 | Helsinn Healthcare Sa | Therapeutic Uses of Elsiglutide |
| US11389424B2 (en) | 2017-03-09 | 2022-07-19 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating chemotherapy-induced diarrhea |
| IL271245B2 (en) * | 2017-06-16 | 2023-10-01 | Zealand Pharma As | Dosing regimen for administration of glucagon-like peptide analog (GLP-2) 2 |
| MX2022016367A (es) * | 2020-06-19 | 2023-01-30 | Napo Pharmaceuticals Inc | Metodos y composiciones para el tratamiento de la diarrea inducida por quimioterapia. |
| CN115054683B (zh) * | 2022-05-19 | 2023-06-09 | 唐颢 | 胰高血糖素样肽-2在制备缓解阿霉素心脏毒性药物中的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200709027B (en) * | 2005-04-22 | 2009-01-28 | Novacea Inc | Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof |
| DE602006020123D1 (de) * | 2005-05-04 | 2011-03-31 | Zealand Pharma As | Glucagon-like-peptide-2- (glp-2-) analoga |
| EP2314616A1 (en) * | 2009-10-23 | 2011-04-27 | Ferring B.V. | Peptidic GLP-2 agonists |
-
2015
- 2015-09-01 US US14/842,250 patent/US20160067311A1/en not_active Abandoned
- 2015-09-02 MX MX2017003166A patent/MX2017003166A/es unknown
- 2015-09-02 SG SG11201701690WA patent/SG11201701690WA/en unknown
- 2015-09-02 CA CA2959110A patent/CA2959110A1/en not_active Abandoned
- 2015-09-02 EP EP15795220.1A patent/EP3191115A1/en not_active Withdrawn
- 2015-09-02 WO PCT/IB2015/001922 patent/WO2016038455A1/en not_active Ceased
- 2015-09-02 KR KR1020177009656A patent/KR20170052661A/ko not_active Withdrawn
- 2015-09-02 BR BR112017004577A patent/BR112017004577A2/pt not_active Application Discontinuation
- 2015-09-02 AU AU2015313919A patent/AU2015313919A1/en not_active Abandoned
- 2015-09-02 EA EA201790552A patent/EA201790552A1/ru unknown
- 2015-09-02 CN CN201580060760.4A patent/CN107073081A/zh active Pending
- 2015-09-02 MA MA040623A patent/MA40623A/fr unknown
- 2015-09-02 JP JP2017513522A patent/JP2017532308A/ja active Pending
- 2015-09-04 TW TW104129362A patent/TW201613634A/zh unknown
- 2015-09-09 AR ARP150102872A patent/AR103119A1/es unknown
-
2017
- 2017-03-05 IL IL250928A patent/IL250928A0/en unknown
- 2017-03-07 PH PH12017500426A patent/PH12017500426A1/en unknown
- 2017-03-08 CL CL2017000563A patent/CL2017000563A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2959110A1 (en) | 2016-03-17 |
| MX2017003166A (es) | 2017-06-19 |
| MA40623A (fr) | 2016-03-17 |
| CL2017000563A1 (es) | 2017-09-29 |
| AU2015313919A1 (en) | 2017-03-16 |
| KR20170052661A (ko) | 2017-05-12 |
| JP2017532308A (ja) | 2017-11-02 |
| CN107073081A (zh) | 2017-08-18 |
| BR112017004577A2 (pt) | 2018-01-23 |
| TW201613634A (en) | 2016-04-16 |
| PH12017500426A1 (en) | 2017-07-31 |
| EA201790552A1 (ru) | 2017-08-31 |
| US20160067311A1 (en) | 2016-03-10 |
| SG11201701690WA (en) | 2017-04-27 |
| WO2016038455A1 (en) | 2016-03-17 |
| IL250928A0 (en) | 2017-04-30 |
| EP3191115A1 (en) | 2017-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20170095A (es) | Anticuerpos anti-cll-1 e inmunoconjugados referencias recíprocas con solicitudes relacionadas | |
| TR201810635T4 (tr) | Anti-jagged1 antikorları ve kullanım yöntemleri. | |
| EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
| EA201691991A1 (ru) | Мультиспецифические антитела | |
| MX2017007049A (es) | Anticuerpos anti-cd79b y métodos de uso. | |
| MX2017005920A (es) | Anticuerpos anti-tim3 y metodos de uso. | |
| BR112019012343A2 (pt) | anticorpos il-11ra | |
| CR20160500A (es) | Anticuerpos anti-ox40 y métodos de uso | |
| BR112016018521A2 (pt) | composição, e, kit. | |
| EA201790380A1 (ru) | Ингибиторы mk2 и их применения | |
| CL2016003074A1 (es) | Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer. | |
| PT3393485T (pt) | Composições probióticas e uso das mesmas | |
| MX2017006953A (es) | Medicamentos para disminuir la evolucion de la enfermedad de parkinson. | |
| TR201909125T4 (tr) | Yüzey temi̇zlemek i̇çi̇n bi̇r aparat | |
| CL2017000563A1 (es) | Uso de elsiglutida para tratar mucositis gastrointestinal que incluye diarrea inducida por quimioterapia. | |
| CL2018002638A1 (es) | Ambrisentan para uso en el tratamiento de insuficiencia renal aguda | |
| MX383561B (es) | Composiciones y kits para usarse en el tratamiento de un sujeto con síntomas de accidente cerebrovascular o infarto agudo de miocardio (iam). | |
| JP2015043197A5 (enExample) | ||
| EA201792492A1 (ru) | Aml-антигены и их применение | |
| MX380683B (es) | Lisobactina para su uso en el tratamiento de la mastitis bovina. | |
| ES2708968B2 (es) | Cuerda para uso en ambientes explosivos | |
| UA114708U (uk) | Тяговий привід електробуса | |
| TH1901003761A (th) | แอนติบอดีต่อ lif และการใช้ของมัน | |
| CL2015001096S1 (es) | Carcasa para uso en voladuras. | |
| RU2014117250A (ru) | Шахматное судоку |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |